Skip to search formSkip to main contentSkip to account menu

Lercanidipine hydrochloride

Known as: 3,5-Pyridinedicarboxylic Acid, 1,4-Dihydro-2,6-Dimethyl-4-(3-Nitrophenyl)-, 2-((3,3-Diphenylpropyl)Methylamino)-1,1-Dimethylethyl Methyl Ester, Monohydrochloride, lercanidipine hcl 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract Objective: Lercanidipine hydrochloride and felodipine sustained-release tablets comparison for the treatment of patients… 
2015
2015
Results: The blood pressure in group A was already lower than in group B and group C at week 4 after treatment initiation… 
2014
2014
Formulating a poorly insoluble drug as suspension, emulsion or any other liquid dosage form and filling in hard gelatin capsule… 
2013
2013
A simple, rapid, and reliable ultra-performance LC assay method has been developed for the simultaneous estimation of orally… 
2012
2012
Acute vertical gaze palsy is one of the main clinical manifestations of rostral midbrain and paramedian thalamic infarctions, in… 
Review
2011
Review
2011
Even with the availability of novel and efficacious antihypertensive agents, an insufficient number of hypertensive patients… 
2010
2010
A simple, precise and accurate HPLC method has been developed and validated for assay of lercanidipine hydrochloride in tablets… 
2010
2010
ABSTRACT ABSTRACT ABSTRACT A reverse phase HPLC method was developed for quantitative determination of Lercanidipine… 
2009
2009
Three simple and sensitive visible spectrophotometic methods (A-C) have been developed for the assay of Lercanidipine… 
2003
2003
Lercanidipine HCl is poorly absorbed after oral administration with peak plasma concentrations in 1 to 3 hours after a dose…